ScholarIQanswers from OpenAlex & ORCID
Martin Bornhäuser
ResearcherPublications, citations & collaboration network
Martin Bornhäuser is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Martin Bornhäuser have?
ScholarIQindexed works
Martin Bornhäuser has 1,091 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Martin Bornhäuser have?
ScholarIQcitation count
Martin Bornhäuser has 39,763 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Martin Bornhäuser?
ScholarIQh-index
Martin Bornhäuser has an h-index of 96 in OpenAlex.
What is the i10-index of Martin Bornhäuser?
ScholarIQi10-index
Martin Bornhäuser has an i10-index of 517 in OpenAlex.
What is the ORCID of Martin Bornhäuser?
ScholarIQorcid
The ORCID for Martin Bornhäuser is on the source record.
What is the OpenAlex record for Martin Bornhäuser?
ScholarIQopenalex
The OpenAlex for Martin Bornhäuser is on the source record.
What are the most-cited papers on Martin Bornhäuser?
ScholarIQmost cited works
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
Christian Thiede, Christine Steudel, Brigitte Mohr, Markus Schaich, Ulrike Schäkel, Uwe Platzbecker, Martin Wermke, Martin Bornhäuser, Markus Ritter, Andreas Neubauer, Gerhard Ehninger, Thomas Illmer
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Sally Arai, Mukta Arora, Tao Wang, Stephen R. Spellman, Wensheng He, Daniel R. Couriel, Álvaro Urbano-Ispizúa, Corey Cutler, Andrea A. Bacigalupo, Minoo Battiwalla, Mary E.D. Flowers, Mark Juckett, Stephanie J. Lee, Alison W. Loren, Thomas R. Klumpp, Susan E. Prockup, Olle Ringdén, Bipin N. Savani, Gèrard Socié, Kirk R. Schultz, Thomas R. Spitzer, Takanori Teshima, Christopher Bredeson, David A. Jacobsohn, Robert J. Hayashi, William R. Drobyski, Haydar Frangoul, Görgün Akpek, Vincent T. Ho, Victor Lewis, Robert Peter Gale, John Koreth, Nelson J. Chao, Mahmoud Aljurf, Brenda Cooper, Mary J. Laughlin, Jack W. Hsu, Peiman Hematti, Leo F. Verdonck, Melhelm M. Solh, Maxim Norkin, Vijay Reddy, Rodrigo Martino, Shahinaz M. Gadalla, Jenna D. Goldberg, Philip L. McCarthy, José Antonio Pérez‐Simón, Nandita Khera, Ian D. Lewis, Yoshiko Atsuta, Richard F. Olsson, Wael Saber, Edmund K. Waller, Didier Blaise, Joseph A. Pidala, Paul J. Martin, Prakash Satwani, Martin Bornhäuser, Yoshihiro Inamoto, Daniel J. Weisdorf, Mary M. Horowitz, Steven Z. Pavletic
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
Uwe Platzbecker, Martin Wermke, J. Radke, Uta Oelschlaegel, Franzi Seltmann, Alexander Kiani, I-M Klut, Holger Knoth, Christoph Röllig, Johannes Schetelig, Brigitte Mohr, Xina Graehlert, Gerhard Ehninger, Martin Bornhäuser, Christian Thiede
Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
Armin Ehninger, Michael Krämer, Christoph Röllig, Christian Thiede, Martin Bornhäuser, Malte von Bonin, Martin Wermke, Anja Feldmann, Michael Bachmann, Gerhard Ehninger, Uta Oelschlägel, on behalf of the Study Alliance Leukemia
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial
Christoph Röllig, Christian Thiede, Martin Gramatzki, Walter E. Aulitzky, H. Bodenstein, Martin Bornhäuser, Uwe Platzbecker, Reingard Stuhlmann, Ulrich S. Schuler, Silke Soucek, Michael Krämer, Brigitte Mohr, Uta Oelschlaegel, Friedrich Stölzel, Malte von Bonin, Martin Wermke, Hannes Wandt, Gerhard Ehninger, Markus Schaich, for the Study Alliance Leukemia